Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. SXTP
SXTP logo

SXTP News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

SXTP News

U.S. Stocks Rise in Morning Trading, Dow Up Over 100 Points

Jan 26 2026Benzinga

Baker Hughes Q4 Earnings Exceed Expectations

Jan 26 2026Benzinga

Abbott Laboratories (ABT) Reports Q4 Sales Below Expectations, Stock Drops 7%

Jan 22 2026Benzinga

60 Degrees Pharmaceuticals (SXTP) Partners with Runway Health to Launch Arakoda, Stock Surges 161%

Jan 22 2026stocktwits

Procter & Gamble (PG) Stock Rises 2% After Beating EPS Estimates in Mixed Q2 Results

Jan 22 2026Benzinga

60 Degree Pharmaceuticals (SXTP) Announces 1-for-4 Reverse Stock Split to Regain Nasdaq Compliance

Jan 16 2026NASDAQ.COM

60 Degrees Pharmaceuticals (SXTP) to Implement 1-for-4 Reverse Stock Split Effective January 20, 2026

Jan 15 2026seekingalpha

60 Degrees Pharma Confirms B-FREE Study for ARAKODA® in Chronic Babesiosis Treatment

Dec 29 2025Globenewswire

SXTP Events

02/02 08:20
60 Degrees Pharmaceuticals Partners with GoodRx for Up to 30% Savings on Arakoda
60 Degrees Pharmaceuticals (SXTP) announced a partnership with GoodRx (GDRX) to offer eligible consumers savings of up to 30% on Arakoda. Starting February 2, 2026, eligible patients can use GoodRx to access a self-pay price for ARAKODA at more than 70,000 pharmacies nationwide, or can have the medication delivered to their home.
01/28 08:10
60 Degrees Pharmaceuticals Secures Exclusive License with FSU
60 Degrees Pharmaceuticals announced it has exercised the option in its agreement with Florida State University, FSU, to negotiate an exclusive license to use large-scale purification techniques to extract castanospermine from the seeds of Castanospermum australe. Castanospermum australe grows primarily in the Australian states of Queensland and New South Wales, but also in Florida, Hawaii, and California.
01/22 08:30
60 Degrees Pharmaceuticals Partners with Runway Health to Promote ARAKODA
60 Degrees Pharmaceuticals announced a partnership with Runway Health to expand pre-departure access to ARAKODA for prevention of malaria among international travelers through the Runway Health travel medicine platform. The partnership with Runway Health commences April 2, 2026. It adds a new platform to the 60 Degrees Pharma ARAKODA marketing strategy, where eligible users can match their travel itinerary with a personalized medical treatment plan designed by a U.S. licensed healthcare provider.

SXTP Monitor News

60 Degrees Pharmaceuticals Announces Reverse Stock Split to Boost Nasdaq Compliance

Jan 22 2026

SXTP Earnings Analysis

No Data

No Data

People Also Watch